Mednet Logo
HomeRadiation OncologyQuestion

Should combined brachytherapy/EBRT/ADT be the standard of care for men with high-risk prostate cancer?

6
2 Answers
Mednet Member
Mednet Member
Radiation Oncology · NYU Langone

The results of the ASCENDE-RT trial are obviously very encouraging and corroborate findings from single institution studies that combined brachytherapy and external beam radiotherapy in conjunction with hormonal therapy is associated with superior outcomes compared to dose escalated external beam ra...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Sarasota Memorial Hospital

I completely concur with @Dr. First Last's statements. The robust improvement in biochemical control with a relatively short median follow-up portends long-term improvents in clinical outcomes for these patients. As is stated in the question, it is important to keep in mind that this study did enrol...

Register or Sign In to see full answer

Should combined brachytherapy/EBRT/ADT be the standard of care for men with high-risk prostate cancer? | Mednet